thiotepa has been researched along with Cross Infection in 1 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Cross Infection: Any infection which a patient contracts in a health-care institution.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morrison, VA | 1 |
| Weinshel, EL | 1 |
| Luikart, SD | 1 |
1 other study available for thiotepa and Cross Infection
| Article | Year |
|---|---|
Corynebacterium JK: a new pathogen in ventriculostomy infections.
Topics: Corynebacterium Infections; Cross Infection; Dexamethasone; Drug Delivery Systems; Eye Neoplasms; Hu | 1991 |